Veeva Systems Outperforms S&P With 2.1% Gain Ahead of Q4 Earnings
Veeva Systems shares advanced 2.1%, outperforming the S&P 500’s 0.77% gain, despite a 23.2% drop over the past month versus a 0.28% sector decline. Investors await March 4 earnings, with Q4 EPS seen at $1.92 (+10.3%) on $808.9M revenue (+12.2%).
1. Recent Stock Performance and Market Comparison
In the latest session, shares rose 2.1%, outpacing the S&P 500’s 0.77% gain and the Nasdaq’s 1.05% uplift. Over the past month, the stock has fallen 23.2%, lagging the Medical sector’s 0.28% loss and the S&P 500’s 0.98% decline.
2. Upcoming Earnings Expectations
Veeva is scheduled to report Q4 results on March 4, with analysts forecasting EPS of $1.92, a 10.3% increase year-over-year, and revenue of $808.9 million, up 12.2% from the prior year’s quarter.
3. Valuation Metrics and Analyst Consensus
Full-year estimates call for $7.93 in EPS (+20.2%) and $3.17 billion in revenue (+15.3%). The stock trades at a forward P/E of 20.28 versus the industry’s 21.37, carries a PEG of 0.85 against a 1.24 average, and holds a consensus Hold rating.